Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
At a press conference at 12:00 on Friday, 30 March 2007, at the Geneva Palexpo, reporters will have the chance to hear senior scientists, clinicians and representatives of the World Health Organization (WHO) brief them on the latest approaches to targeted therapies, chemotherapy and, most crucially, the prevention of lung cancer. The press conference marks the opening of the European Society for Medical Oncologys International Symposium (EIS) on Chest Tumors.
"Over the next 25 years, the number of lung cancer deaths is projected to nearly double to 2.2 million in 2030," according to WHO projections.
"The most effective way to fight lung cancer is to prevent it," said Dr. Catherine Le Gals-Camus, Assistant Director-General, Noncommunicable Diseases and Mental Health at the World Health Organization. "Effective prevention means combating the global epidemic of tobacco use and the other known environmental factors causing lung cancer, whether that is reducing exposure to coal-burning indoors or to ozone outdoors."
While in Geneva hosting the EIS on Chest Tumors, ESMO senior executives will meet with WHO officials to discuss ways of collaborating and strengthening clinicians involvement to improve prevention and treatment for lung cancer.
"Cancer prevention spans a wide range of disciplines," said ESMO president, Hkan Mellstedt. These include population, nutrition, behavioral, environmental and social sciences; diagnostics; and clinical therapeutics like chemoprevention. "All of these help to identify and quantify cancer risk in individuals and family, ethnic, and racial groups. This is the main reason why cancer can truly be fought on all fronts and by all those who are touche
Contact: Vanessa Pavinato
European Society for Medical Oncology